openPR Logo
Press release

Liposomal Drug Delivery Devices: A Leading Driver Behind Global Increase In Cancer Cases Fuels Growth Of Liposomal Drug Delivery Devices Market Market Expansion in 2025

10-09-2025 09:32 AM CET | Health & Medicine

Press release from: The Business Research Company

Liposomal Drug Delivery Devices Market

Liposomal Drug Delivery Devices Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Liposomal Drug Delivery Devices Industry Market Size Be by 2025?
The market size for liposomal drug delivery devices has seen robust growth in recent times. The projection is for it to rise from $4.89 billion in 2024 to $5.34 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.4%. This growth trajectory during the historic period stemmed from advances in drug delivery techniques, progress in biomedical research, clinical verification, the use of therapeutic applications, and enhancements in biocompatibility.

What's the Long-Term Growth Forecast for the Liposomal Drug Delivery Devices Market Size Through 2029?
The market for liposomal drug delivery devices is anticipated to significantly expand in the coming years, with a projection to reach a value of $8.48 billion in 2029, experiencing a compound annual growth rate (CAGR) of 12.2%. This upcoming growth trend can be linked to the expansion of targeted therapies, extensive clinical validation and trials, a focus on personalized medicine, development of combination therapies, and changes in regulatory landscapes. Key trends during this forecast period will likely include the use of biocompatible liposomal materials, innovative delivery systems, use in oncology, the development of combination therapies, and tailor-made liposome formulations.

View the full report here:
https://www.thebusinessresearchcompany.com/report/liposomal-drug-delivery-devices-global-market-report

What Are the Key Growth Drivers Fueling the Liposomal Drug Delivery Devices Market Expansion?
The global increase in cancer cases is expected to bolster the liposomal drug delivery devices market during the predicted timeframe. Liposomal drug delivery mechanisms are utilized for cancer-targeted therapy in chemotherapy, radiation therapy, and surgical resection. For instance, the Macmillan Cancer Support, a cancer charity based in the UK, reported in June 2022, that the population of cancer patients had reached 3 million in 2022, and was expected to escalate to almost 3.5 million by 2025, and 4 million by 2030 in the UK. Consequently, the global surge in cancer rates is projected to enhance the demand for the liposomal drug delivery devices market in the upcoming years.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3349&type=smp

What Are the Key Trends Driving Liposomal Drug Delivery Devices Market Growth?
Numerous large corporations are executing various tactical plans, including developing new products. These efforts are set to significantly influence trends in the liposomal drug delivery devices market. Several such corporations are joining forces to engineer liposomal drug delivery systems, aiming to broaden their range of products and global operations. An example is Insmed, Inc., a biotech firm based in the US, which shared data from the ARISE research on ARIKAYCE (amikacin liposome inhalation suspension) in May 2024. Patients who received ARIKAYCE outperformed those in the comparison group (which used a macrolide-based multi-drug regimen), achieving an improved QOL-B respiratory score in 43.8% of the cases, as assessed by the QOL-B tool.

How Is the Liposomal Drug Delivery Devices Market Segmented?
The liposomal drug delivery devices market covered in this report is segmented -

1) By Type: Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, Other Types
2) By Application: Fungal Diseases, Cancer Therapy, Pain Management, Viral Vaccines, Photodynamic Therapy
3) By End User: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Other End Users

Subsegments:
1) By Liposomal Doxorubicin: Conventional Liposomal Doxorubicin, PEGylated Liposomal Doxorubicin
2) By Liposomal Paclitaxel: Conventional Liposomal Paclitaxel, PEGylated Liposomal Paclitaxel
3) By Liposomal Amphotericin B: Conventional Liposomal Amphotericin B, PEGylated Liposomal Amphotericin B
4) By Other Types: Liposomal Irinotecan, Liposomal Vincristine, Liposomal Cytarabine

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3349&type=smp

Which Companies Are Leading the Charge in Liposomal Drug Delivery Devices Market Innovation?
Major companies operating in the liposomal drug delivery devices market include Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Novartis AG, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., CSPC Pharmaceutical Group Limited, Ipsen SA, Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co. Ltd., Nanomerics Ltd., Luye Pharma Group Ltd., Leadiant Biosciences Inc., Pacira Biosciences Inc., Nippon Kayaku Co. Ltd., Celsion Corporation, Acrotech Biopharma Inc., Aphios Pharma LLC, CytImmune Sciences Inc., NanoSphere Health Sciences Inc., Cel-Sci Corporation, Lipoid GmbH, Liposome Company Inc., Liposome Research Days Corporation, Taiwan Liposome Company, T&T Scientific Corporation

Which Regions Are Leading the Global Liposomal Drug Delivery Devices Market in Revenue?
North America was the largest region in the liposomal drug delivery devices market in 2024. Asia-Pacific was the second-largest region in the global liposomal drug delivery devices market share. The regions covered in the liposomal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3349

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Liposomal Drug Delivery Devices: A Leading Driver Behind Global Increase In Cancer Cases Fuels Growth Of Liposomal Drug Delivery Devices Market Market Expansion in 2025 here

News-ID: 4215461 • Views:

More Releases from The Business Research Company

Surge In Funding And Investments Accelerates Growth In The Microbiology Diagnostic Devices Market: Strengthening the Growth Trajectory of the Microbiology Diagnostic Devices And Equipment Market
Surge In Funding And Investments Accelerates Growth In The Microbiology Diagnost …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Microbiology Diagnostic Devices And Equipment Market Through 2025? Over the recent years, the market size for microbiology diagnostic devices and equipment has expanded significantly. It is projected to escalate from $5.51 billion in 2024 to $6.43 billion in 2025, with a compound
Top Market Shifts Transforming the Tele-Dermatology Prescription Market Landscape: Key Insights
Top Market Shifts Transforming the Tele-Dermatology Prescription Market Landscap …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Tele-Dermatology Prescription Market Through 2025? The market for prescriptions in tele-dermatology has seen significant expansion in the past few years. The growth is projected to escalate from $1.91 billion in 2024 to reach $2.33 billion in 2025, representing a compound annual growth
Rising Incidence Of Aortic Aneurysms Fuels Expansion Of Aortic Endograft Market: Pivotal Factor Influencing Aortic Endograft Market Growth in 2025
Rising Incidence Of Aortic Aneurysms Fuels Expansion Of Aortic Endograft Market: …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Aortic Endograft Market Size Growth Forecast: What to Expect by 2025? There has been significant growth in the size of the aortic endograft market in recent years. The market is projected to expand from $3.35 billion in 2024 to $3.52 billion in 2025, corresponding to a compound annual growth
Wearable Blood Pressure Monitors Market Expansion Continues, with Forecast Valuation of $3.06 Billion by 2029
Wearable Blood Pressure Monitors Market Expansion Continues, with Forecast Valua …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Wearable Blood Pressure Monitors Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size of wearable blood pressure monitors has seen a significant increase in the past few years. It is estimated to rise from $1.53 billion in 2024 to reach $1.74 billion in

All 5 Releases


More Releases for Liposomal

What is Liposomal Vitamin C? | ONS & FSMP Guide
What Does "Liposomal" Mean? Understanding Liposomal Vitamin C. Image: https://ecdn6.globalso.com/upload/p/2011/image_other/2025-08/wechat_2025-08-06_015004_689.png Modern supplements promise more than ever, yet many nutrients break down before your body can use them. SINOFN Health harnesses liposomal technology to protect vitamins like vitamin C in tiny phospholipid spheres-so they glide through digestion intact and deliver maximum potency. How Liposomes Work * They encapsulate water-soluble nutrients at their core or embed fat-soluble compounds in their lipid layers. * When liposomes reach the
Rising Prevalence Of Cancer Fuels Growth In Liposomal Doxorubicin Market: A Sign …
The Liposomal Doxorubicin Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Liposomal Doxorubicin Market Size and Projected Growth Rate? The liposomal doxorubicin market has also shown strong growth in recent years. It is expected to grow from $1.23 billion in 2024 to $1.32
Key Trend Reshaping the Liposomal Drug Delivery Devices Market in 2025: Strategi …
What industry-specific factors are fueling the growth of the liposomal drug delivery devices market? The global increase in cancer cases is expected to bolster the liposomal drug delivery devices market in the future. These delivery systems offer targeted treatments for cancer through radiation therapy, chemotherapy, and surgical resection. For example, data from UK-based charity, Macmillan Cancer Support, in June 2022, revealed a cancer prevalence of 3 million in 2022, which is
Liposomal Supplements Market Research Report 2023
Liposomal Supplements Market The global Liposomal Supplements market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-31J7848/Global_and_China_Liposomal_Supplements_Market_Insights_Forecast_to_2027 North American market for Liposomal Supplements is estimated to increase from $ million in 2023 to reach $ million by 2029,
Liposomal Supplements Market Research Report 2023 - valuates reports
The global Liposomal Supplements market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. North American market for Liposomal Supplements is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of %
Liposomal Doxorubicin Market - Powerful Delivery, Enhanced Outcomes: Empowering …
Newark, New Castle, USA - new report, titled Liposomal Doxorubicin Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Liposomal Doxorubicin market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Liposomal Doxorubicin market. The report offers an overview of the market, which